HCA Healthcare, Inc. Quarterly Report for Q2 Ended Jun 30, 2019

Summary

HCA Healthcare, Inc. reported a solid performance for the second quarter of 2019, with revenues increasing by 9.3% to $12.602 billion compared to the prior year period. This growth was driven by a combination of increased patient volumes (6.2% rise in equivalent admissions) and a 3.0% increase in revenue per equivalent admission. While consolidated revenues showed strong growth, net income attributable to HCA Healthcare, Inc. saw a slight decrease to $783 million ($2.25 per diluted share) from $820 million ($2.31 per diluted share) in the second quarter of 2018. This decline in net income, despite revenue growth, can be attributed to increased operating expenses, particularly in salaries, benefits, and supplies, as well as higher interest expenses related to increased debt levels and a rise in depreciation and amortization. Operationally, the company experienced positive trends in admissions (up 4.8% consolidated, 2.1% same facility) and emergency department visits (up 4.9% consolidated, 3.0% same facility). Same-facility uninsured admissions also increased by 5.1%, highlighting continued demand from a diverse patient base. The company is actively managing its capital structure, issuing new debt and repurchasing shares, while also undertaking significant capital expenditures for facility improvements and expansions. Despite the increase in revenue, investors should note the slight dip in net income and the growing debt burden, which are key areas to monitor. The company also highlighted its strategic focus on expanding its network through acquisitions, notably a seven-hospital system in North Carolina. Cash flow from operations remained robust, increasing by $415 million year-over-year. Management expressed confidence in the company's liquidity and ability to meet its financial obligations for the next 12 months.

Key Highlights

• 1Total revenues for Q2 2019 increased by 9.3% to $12.602 billion, compared to $11.529 billion in Q2 2018.
• 2Net income attributable to HCA Healthcare, Inc. decreased to $783 million ($2.25/share) in Q2 2019 from $820 million ($2.31/share) in Q2 2018.
• 3Consolidated equivalent admissions increased by 6.2% and revenue per equivalent admission increased by 3.0% in Q2 2019.
• 4Cash flows from operating activities increased by $415 million to $1.997 billion in Q2 2019.
• 5The company made significant acquisitions, including a seven-hospital system in North Carolina, and invested heavily in capital expenditures, totaling $1.745 billion (excluding acquisitions) in the first six months of 2019.
• 6Total debt stood at $36.193 billion as of June 30, 2019, with interest expense rising to $938 million for the first six months of 2019.
• 7HCA repurchased $520 million of its common stock in the first six months of 2019.

Frequently Asked Questions